AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has approved Fasenra (benralizumab) for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and
Related Posts
Asthma: Wirksamkeit von Mepolizumab bestätigt
Mepolizumab hat erneut seine Wirksamkeit bei schwerem refraktärem eosinophilem Asthma erwiesen. Entscheidend für die Therapie ist die richtige Auswahl der Patienten. … lesen Sie weiter! Quelle: : http://www.aerztezeitung.de/medizin/krankheiten/asthma/article/937670/asthma-wirksamkeit-mepolizumab-bestaetigt.html
Smart Gardening: Tips for an Allergy-Friendly Garden
If you have asthma or allergies, you don’t have to decorate your yard with stones and concrete. There are many plants you can use in your home garden that won’t affect your allergies. You can choose from several flowers, shrubs,